Search research articles
Contact Us
Filters
Showing results (261-270 of 280) with videos related to
Page
of 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2021
Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring
Caitlin M Stewart, Laure Michaud, Karissa Whiting, et al.
Haematologica
|
August 30, 2023
Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
Zachary D Epstein-Peterson, Esther Drill, Umut Aypar, et al.
Haematologica
|
August 1, 2024
<i>Erratum</i> to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
Zachary D Epstein-Peterson, Esther Drill, Umut Aypar, et al.
Leukemia & Lymphoma
|
July 2, 2025
Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis
Efrat Luttwak, Edith Tama Robin, Esther Drill, et al.
Blood
|
September 7, 2017
Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
Alison J Moskowitz, Heiko Schöder, Somali Gavane, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 14, 2020
Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma
Connie L Batlevi, Fushen Sha, Anna Alperovich, et al.
Blood Cancer Journal
|
July 18, 2020
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
Connie L Batlevi, Fushen Sha, Anna Alperovich, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 16, 2011
Hodgkin lymphoma
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816
Oliver W Press, Hongli Li, Heiko Schöder, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 10, 2012
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 280) with videos related to
Sort By:
Page
of 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2021
Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring
Caitlin M Stewart, Laure Michaud, Karissa Whiting, et al.
Haematologica
|
August 30, 2023
Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
Zachary D Epstein-Peterson, Esther Drill, Umut Aypar, et al.
Haematologica
|
August 1, 2024
<i>Erratum</i> to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
Zachary D Epstein-Peterson, Esther Drill, Umut Aypar, et al.
Leukemia & Lymphoma
|
July 2, 2025
Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis
Efrat Luttwak, Edith Tama Robin, Esther Drill, et al.
Blood
|
September 7, 2017
Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
Alison J Moskowitz, Heiko Schöder, Somali Gavane, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 14, 2020
Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma
Connie L Batlevi, Fushen Sha, Anna Alperovich, et al.
Blood Cancer Journal
|
July 18, 2020
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
Connie L Batlevi, Fushen Sha, Anna Alperovich, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 16, 2011
Hodgkin lymphoma
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2016
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816
Oliver W Press, Hongli Li, Heiko Schöder, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 10, 2012
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Page
of 28